Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 03 Jun 2022 for Genocea Biosciences, INC., €88. Read the official filing
Filing timeline
BuySaleJessica Baker Flechtner
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jessica Baker Flechtner: trading record in brief
Jessica Baker Flechtner is a declared insider of Genocea Biosciences, Inc. (senior executive), with filings sourced from SEC (Form 4). In total, 4 filings cover trades dated from 15 March 2022 to 2 June 2022.
The open-market record consists of 3 sales worth €2,831, with no purchase. Other entries cover 1 share grant.
On 3 June 2022 came the latest disclosure, an open-market sale for €88 in Genocea Biosciences, Inc. Typically, a trade is published a median of 1 day after it takes place. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jessica Baker Flechtner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
1,578 shares@ US$0.063.1% of flowCommon StockSEC:0001457612-22-000074:0
16,525 shares@ US$0.088148.1% of flowCommon StockSEC:0001457612-22-000061:0
1,212 shares@ US$1.2548.8% of flowCommon StockSEC:0001457612-22-000046:0
43,750 shares0Common StockSEC:0001457612-22-000032:0
4 of 4 declarations
